-+ 0.00%
-+ 0.00%
-+ 0.00%

3 Asian Growth Companies Insiders Own With Up To 28% Revenue Growth

Simply Wall St·07/28/2026 04:05:31
语音播报

The Asian market has been navigating a complex landscape marked by geopolitical tensions, fluctuating oil prices, and evolving economic policies. Amidst these challenges, investors are increasingly focusing on growth companies with high insider ownership, as such ownership can signal confidence in the company's future prospects and alignment of interests between management and shareholders.

Top 10 Growth Companies With High Insider Ownership In Asia

Name Insider Ownership Earnings Growth
Zhejiang Taotao Vehicles (SZSE:301345) 27.9% 31.5%
Shanghai Biren Technology (SEHK:6082) 11% 116.9%
SEERS (KOSDAQ:A458870) 33.2% 41.5%
Meitu (SEHK:1357) 22.8% 31.3%
Meiko Electronics (TSE:6787) 19.2% 28.0%
HUMAN MADE (TSE:456A) 23.9% 23.4%
Great Microwave Technology (SHSE:688270) 29.5% 85.5%
Gold Circuit Electronics (TWSE:2368) 30.1% 38.2%
Fulin Precision (SZSE:300432) 10.4% 60.7%
Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) 14.1% 40.4%

Click here to see the full list of 491 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Akeso (SEHK:9926)

Simply Wall St Growth Rating: ★★★★★★

Overview: Akeso, Inc. is a biopharmaceutical company focused on the research, development, manufacture, and commercialization of antibody drugs globally, with a market cap of HK$90.82 billion.

Operations: The company generates revenue of CN¥3.06 billion from its activities in the research, development, production, and sale of biopharmaceutical products.

Insider Ownership: 18.2%

Revenue Growth Forecast: 28.6% p.a.

Akeso is positioned as a growth company with significant insider ownership, benefiting from robust strategic collaborations and innovative drug developments. Recent partnerships, like the collaboration with Memorial Sloan Kettering Cancer Center for cadonilimab trials, underscore its commitment to advancing cancer therapies. With revenue expected to grow at 28.6% annually and earnings projected to rise by 46.21% per year, Akeso's financial outlook appears promising amid strong insider confidence and ongoing clinical advancements in oncology treatments.

SEHK:9926 Ownership Breakdown as at Jul 2026
SEHK:9926 Ownership Breakdown as at Jul 2026

Shenzhen Capchem Technology (SZSE:300037)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shenzhen Capchem Technology Co., Ltd. operates in the research, development, production, sale, and service of new electronic chemicals and functional materials both in China and internationally, with a market cap of CN¥46.90 billion.

Operations: Shenzhen Capchem Technology Co., Ltd. generates its revenue through the development and sale of innovative electronic chemicals and functional materials across domestic and international markets.

Insider Ownership: 39.1%

Revenue Growth Forecast: 20.9% p.a.

Shenzhen Capchem Technology demonstrates potential as a growth entity with significant insider ownership, supported by its earnings and revenue forecasts that outpace the broader CN market. Despite high share price volatility and an unstable dividend record, its Price-To-Earnings ratio of 34.8x suggests reasonable valuation relative to the market average. Recent amendments to company bylaws indicate strategic adjustments in governance structure, potentially aligning with future growth objectives amid strong projected earnings expansion of 26.34% annually.

SZSE:300037 Ownership Breakdown as at Jul 2026
SZSE:300037 Ownership Breakdown as at Jul 2026

Shenzhen Honor Electronic (SZSE:300870)

Simply Wall St Growth Rating: ★★★★★★

Overview: Shenzhen Honor Electronic Co., Ltd. is involved in the research, development, production, and sale of switching power supply products both in China and internationally, with a market cap of CN¥31.94 billion.

Operations: The company's revenue primarily comes from the research, development, production, and sale of switching power supply products in both domestic and international markets.

Insider Ownership: 27.2%

Revenue Growth Forecast: 24.7% p.a.

Shenzhen Honor Electronic's strong growth potential is evident with projected revenue and earnings expansion rates of 24.7% and 49.24% annually, surpassing the broader CN market. Despite recent dividend reductions, its inclusion in key indices suggests increased visibility and investor confidence. However, high share price volatility and declining profit margins from 7.2% to 3.9% could pose challenges. The absence of significant insider trading activity over the past three months indicates stable insider sentiment amidst these dynamics.

SZSE:300870 Earnings and Revenue Growth as at Jul 2026
SZSE:300870 Earnings and Revenue Growth as at Jul 2026

Key Takeaways

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.